Empowering Oncology Decisions

DiagnoCure is a life sciences company commercializing high-value cancer diagnostic tests and lab services that increase clinician and patient confidence in making critical treatment decisions.

Special Announcement

New studies show DiagnoCure’s PCA3 prostate cancer marker can help guide repeat prostate biopsy decisions and predict risk of aggressive cancer

Visit our media room for more information